Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 529 results for "nexium"

Human medicines European public assessment report (EPAR): Ne...

This is a summary of the European public assessment report (EPAR) for Nexium Control. It explains how the European Medicines Agency assessed the medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not ... European Medicines Agency, 1 week ago

27 images for nexium

Rediff.com, 1 week ago
I Stock Analyst, 3 weeks ago
MSN India, 1 month ago
Money Today, 1 month ago
Livemint.com, 1 month ago
WXYZ, 1 month ago
WXYZ, 1 month ago
WXYZ, 1 month ago
WXYZ, 1 month ago
WXYZ, 1 month ago
Money Control

Positives, negatives of Sun-Ranbaxy deal, according to HSBC

We are confident of Diovan and Nexium launch by Ranbaxy which is why we had upgraded stock earlier this year to Neutral. Now with Sun Pharma with Ranbaxy, it is likely that FTFs may monetise soon.
 Money Control1 week ago

AstraZeneca Launches Nexium® (Esomeprazole Magnesium) Direct-to-Patient Program

AstraZeneca Launches Nexium ® (Esomeprazole Magnesium) Direct-to-Patient Program WILMINGTON, Del., March 19, 2014 AstraZeneca today launched NEXIUM Direct, a program that provides eligible patients the option of having brand-name NEXIUM ...
 FierceBiotech3 weeks ago AstraZeneca Launches NEXIUM Direct Program  Pharmaceutical Online4 weeks ago AstraZeneca goes direct with Nexium  Seeking Alpha1 month ago AstraZeneca Unveils Nexium Direct-to-Patient Program - Quick Facts  RTTNews.com1 month ago
[x]  
Reuters

Sell Ranbaxy And Buy AstraZeneca: Good Chance Nexium Generic Launch Delayed

Summary Ranbaxy launch of generic copies of Nexium may be delayed by about 6 months or more. Incremental Profits for Ranbaxy from Nexium generics will be much lower than anticipated because of the delay. Even if they launch it timely, I expect ...
 Seeking Alpha2 weeks ago Ranbaxy in talks on sourcing ingredients for generic Nexium: reports  India Infoline1 month ago Ranbaxy scrambles for ingredients to make generic Nexium  Reuters1 month ago Ranbaxy Seeks Sourcing Suppliers for Generic Nexium  Contract Pharma1 month ago
[x]  

Update on Pfizer's OTC Nexium 24HR

Pipeline updates are eagerly awaited by investors in the biotech/pharma space. An insight into late-stage candidates (including regulatory approval) targeting lucrative markets often influence their investment decisions on a particular stock. Late ...
 Yahoo! Finance2 weeks ago Update on Pfizer's OTC Nexium 24HR - Analyst Blog  Zacks.com2 weeks ago
Pharma Letter

AstraZeneca says Nexium is safe

AstraZeneca (AZN) says Nexium is safe despite an FDA-imposed ban on US shipments on a key ingredient's manufacturer. Ranbaxy Laboratories was slapped with the ban in January because it was allegedly retesting QC-failed products in order to get ...
 Seeking Alpha1 month ago AstraZeneca Says U.S. Nexium Safe With Product From Banned Plant  Bloomberg1 month ago AstraZeneca says Nexium pills with Ranbaxy ingredient are safe to use  FiercePharma1 month ago AstraZeneca Says US Nexium Safe With Product From Banned Plant  FirstWord Pharma1 month ago
[x]  
Bidness Etc

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Today the U.S. Food and Drug Administration (FDA) approved over-the-counter Nexium ® 24HR ( esomeprazole 20mg) marking a key step towards providing those who suffer from frequent heartburn broader access to a brand doctors and patients have trusted ...
 News-Medical.Net2 weeks ago Pfizer : Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR  4 Traders3 weeks ago Pfizer receives US FDA's approval of over-the-counter Nexium 24HR for treating heartburn  Individual.com2 weeks ago Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium 24HR  Drugs.com2 weeks ago
[x]  
NDTV Profit

Daiichi Sankyo lays out road map for Ranbaxy deal with Sun

Will the deal further delay or hasten launch of generic Diovan, Nexium? Share Tools Daiichi Sankyo should be out from under Ranbaxy Laboratories by the end of the year. The Japanese drugmaker today released its road map for the $3.2 billion ...
 FiercePharma1 week ago Sun Pharma hopes to turn fortunes of Ranbaxy around with $3.2B buyout  FiercePharma1 week ago Sun, Ranbaxy merger to create India's biggest drugmaker  NDTV Profit1 week ago India's Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats  4 Traders1 week ago
[x]  

FDA approves OTC Nexium

 Formulary Journal2 weeks ago New OTC Nexium approved  Medical Marketing And Media2 weeks ago US FDA approves OTC drug Nexium 24HR  Pharmaceutical Business Review2 weeks ago With Solvadi in the mix, the FDA's class of 2013 is set for chart-busting sales  FiercePharma1 month ago

Pfizer gets FDA green light for Nexium OTC launch as AZ braces for competition

AstraZeneca ($AZN) has been pulling out all the stops in trying to preserve blockbuster Nexium's revenues for as long as it can. Now, the FDA has approved an over-the-counter version of the drug--but thanks to a 2012 agreement, those sales are on ...
 FiercePharma2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - nexium
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less